US Stock MarketDetailed Quotes

CPIX Cumberland Pharmaceuticals

Watchlist
  • 1.480
  • 0.0000.00%
Trading Jul 22 16:00 ET
21.00MMarket Cap-2508P/E (TTM)

Cumberland Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-50.66%-2.14M
-27.91%6.09M
-71.41%1.04M
-53.08%1.24M
124.64%5.24M
-842.34%-1.42M
94.41%8.45M
149.80%3.64M
540.11%2.64M
5.91%2.33M
Net income from continuing operations
-1,204.25%-1.9M
-12.05%-6.33M
-156.21%-6.3M
-151.22%-1.06M
163.18%862.15K
112.28%172.29K
-56.82%-5.65M
36.67%-2.46M
61.05%-423.23K
-211.54%-1.36M
Operating gains losses
----
--20.26K
----
----
----
----
----
----
----
----
Depreciation and amortization
0.56%1.44M
8.30%5.77M
304.27%2.07M
-19.32%1.25M
-36.43%1.03M
-13.66%1.43M
15.67%5.33M
-52.51%511.48K
43.86%1.54M
31.79%1.62M
Other non cash items
83.38%-355.84K
19.06%-1.71M
67.96%-373.41K
11.39%-771.65K
334.80%1.58M
-459.95%-2.14M
37.69%-2.11M
6.66%-1.17M
-13.36%-870.82K
-25.34%-671.37K
Change In working capital
-44.00%-1.39M
-55.61%4.63M
-66.95%2.19M
-20.68%1.74M
-39.83%1.67M
16.36%-967.33K
27.63%10.44M
25.30%6.62M
10,729.19%2.2M
21.76%2.78M
-Change in receivables
-321.42%-1.07M
155.68%3.4M
21.54%2.51M
97.95%-54.56K
-79.23%463.31K
106.21%481.61K
-211.19%-6.12M
-30.41%2.07M
-277.93%-2.66M
-34.43%2.23M
-Change in inventory
152.69%170.47K
-102.54%-23.14K
-3.20%-441.5K
140.39%650.47K
-86.51%91.45K
-114.24%-323.56K
-81.08%911.08K
-118.92%-427.8K
-756.09%-1.61M
53.54%677.96K
-Change in payables and accrued expense
41.59%-645.54K
-74.38%3.72M
-68.37%1.82M
-66.78%1.37M
730.73%1.64M
-124.77%-1.11M
2,018.72%14.54M
172.09%5.76M
2,957.92%4.12M
111.63%197.39K
-Change in other current assets
-46.40%205.62K
-90.47%65.68K
113.77%505K
-88.33%365.08K
-220.35%-1.19M
59.93%383.61K
2,037.87%689.26K
-120.46%-3.67M
311.43%3.13M
174.30%987.17K
-Change in other current liabilities
85.86%-57.1K
-704.49%-2.54M
-176.40%-2.21M
25.12%-587.26K
150.39%663.66K
-8.76%-403.74K
131.23%419.66K
822.73%2.89M
-87.97%-784.31K
-482.06%-1.32M
Cash from discontinued investing activities
Operating cash flow
-50.66%-2.14M
-27.91%6.09M
-71.41%1.04M
-53.08%1.24M
124.64%5.24M
-842.34%-1.42M
33.28%8.45M
85.64%3.64M
2,683.48%2.64M
-13.66%2.33M
Investing cash flow
Cash flow from continuing investing activities
66.65%-58.19K
99.23%-105.7K
140.68%260.64K
-113.96%-95.07K
43.91%-96.81K
98.71%-174.45K
-2,624.58%-13.67M
-2,291.39%-640.77K
728.95%680.81K
-255.76%-172.59K
Net PPE purchase and sale
61.20%-41.62K
-175.35%-281.27K
-131.70%-48.67K
41.88%-53.14K
47.40%-72.19K
-297.47%-107.26K
1.34%-102.15K
1,797.00%153.53K
-52.51%-91.44K
-810.60%-137.26K
Net intangibles purchase and sale
75.35%-16.57K
91.29%-171.78K
97.88%-38.04K
67.01%-41.93K
30.34%-24.62K
-350.60%-67.19K
-685.74%-1.97M
-2,451.73%-1.79M
-163.23%-127.11K
-5.67%-35.34K
Net business purchase and sale
----
--0
--0
--0
----
----
---13.5M
--0
--0
--0
Net other investing changes
----
-81.71%347.36K
----
----
----
----
3,513.07%1.9M
295.93%1M
----
----
Cash from discontinued investing activities
Investing cash flow
66.65%-58.19K
99.23%-105.7K
140.68%260.64K
-113.96%-95.07K
43.91%-96.81K
98.71%-174.45K
-2,624.58%-13.67M
-2,291.39%-640.77K
728.95%680.81K
-255.76%-172.59K
Financing cash flow
Cash flow from continuing financing activities
236.12%2.42M
-260.10%-7.42M
46.52%-1.49M
55.67%-882.6K
-171.12%-3.28M
-145.41%-1.78M
41.98%-2.06M
-278.19%-2.78M
-619.86%-1.99M
36.52%-1.21M
Net issuance payments of debt
2,683.90%3.3M
-384.65%-3.42M
90.73%-138.98K
82.69%-225K
-192.42%-2.92M
-102.55%-127.71K
--1.2M
---1.5M
-230.00%-1.3M
0.00%-1M
Net common stock issuance
-32.33%-247.61K
29.68%-740.53K
0.36%-188.97K
-168.56%-201.65K
21.80%-162.79K
67.75%-187.12K
24.07%-1.05M
47.49%-189.66K
69.72%-75.09K
56.16%-208.17K
Net other financing activities
56.93%-630.7K
-47.96%-3.27M
-6.23%-1.16M
25.99%-455.94K
---188.68K
-191.98%-1.46M
-1.94%-2.21M
-191.67%-1.09M
-66.96%-616.07K
--0
Cash from discontinued financing activities
Financing cash flow
236.12%2.42M
-260.10%-7.42M
46.52%-1.49M
55.67%-882.6K
-171.12%-3.28M
-145.41%-1.78M
41.98%-2.06M
-278.19%-2.78M
-619.86%-1.99M
36.52%-1.21M
Net cash flow
Beginning cash position
-7.27%18.32M
-26.93%19.76M
-5.29%18.51M
0.18%18.25M
-5.10%16.39M
-26.93%19.76M
9.24%27.04M
-24.38%19.54M
-29.04%18.22M
-30.72%17.27M
Current changes in cash
106.73%226.86K
80.28%-1.44M
-186.10%-186.34K
-80.46%258.88K
96.14%1.86M
65.50%-3.37M
-418.44%-7.28M
-81.93%216.43K
666.90%1.32M
27.05%949.78K
End cash Position
13.20%18.55M
-7.27%18.32M
-7.27%18.32M
-5.29%18.51M
0.18%18.25M
-5.10%16.39M
-26.93%19.76M
-26.93%19.76M
-24.38%19.54M
-29.04%18.22M
Free cash flow
-37.81%-2.19M
-11.58%5.64M
-52.26%953.4K
-52.77%1.14M
138.12%5.14M
-727.80%-1.59M
6.54%6.38M
6.22%2M
1,249.47%2.42M
-18.59%2.16M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -50.66%-2.14M-27.91%6.09M-71.41%1.04M-53.08%1.24M124.64%5.24M-842.34%-1.42M94.41%8.45M149.80%3.64M540.11%2.64M5.91%2.33M
Net income from continuing operations -1,204.25%-1.9M-12.05%-6.33M-156.21%-6.3M-151.22%-1.06M163.18%862.15K112.28%172.29K-56.82%-5.65M36.67%-2.46M61.05%-423.23K-211.54%-1.36M
Operating gains losses ------20.26K--------------------------------
Depreciation and amortization 0.56%1.44M8.30%5.77M304.27%2.07M-19.32%1.25M-36.43%1.03M-13.66%1.43M15.67%5.33M-52.51%511.48K43.86%1.54M31.79%1.62M
Other non cash items 83.38%-355.84K19.06%-1.71M67.96%-373.41K11.39%-771.65K334.80%1.58M-459.95%-2.14M37.69%-2.11M6.66%-1.17M-13.36%-870.82K-25.34%-671.37K
Change In working capital -44.00%-1.39M-55.61%4.63M-66.95%2.19M-20.68%1.74M-39.83%1.67M16.36%-967.33K27.63%10.44M25.30%6.62M10,729.19%2.2M21.76%2.78M
-Change in receivables -321.42%-1.07M155.68%3.4M21.54%2.51M97.95%-54.56K-79.23%463.31K106.21%481.61K-211.19%-6.12M-30.41%2.07M-277.93%-2.66M-34.43%2.23M
-Change in inventory 152.69%170.47K-102.54%-23.14K-3.20%-441.5K140.39%650.47K-86.51%91.45K-114.24%-323.56K-81.08%911.08K-118.92%-427.8K-756.09%-1.61M53.54%677.96K
-Change in payables and accrued expense 41.59%-645.54K-74.38%3.72M-68.37%1.82M-66.78%1.37M730.73%1.64M-124.77%-1.11M2,018.72%14.54M172.09%5.76M2,957.92%4.12M111.63%197.39K
-Change in other current assets -46.40%205.62K-90.47%65.68K113.77%505K-88.33%365.08K-220.35%-1.19M59.93%383.61K2,037.87%689.26K-120.46%-3.67M311.43%3.13M174.30%987.17K
-Change in other current liabilities 85.86%-57.1K-704.49%-2.54M-176.40%-2.21M25.12%-587.26K150.39%663.66K-8.76%-403.74K131.23%419.66K822.73%2.89M-87.97%-784.31K-482.06%-1.32M
Cash from discontinued investing activities
Operating cash flow -50.66%-2.14M-27.91%6.09M-71.41%1.04M-53.08%1.24M124.64%5.24M-842.34%-1.42M33.28%8.45M85.64%3.64M2,683.48%2.64M-13.66%2.33M
Investing cash flow
Cash flow from continuing investing activities 66.65%-58.19K99.23%-105.7K140.68%260.64K-113.96%-95.07K43.91%-96.81K98.71%-174.45K-2,624.58%-13.67M-2,291.39%-640.77K728.95%680.81K-255.76%-172.59K
Net PPE purchase and sale 61.20%-41.62K-175.35%-281.27K-131.70%-48.67K41.88%-53.14K47.40%-72.19K-297.47%-107.26K1.34%-102.15K1,797.00%153.53K-52.51%-91.44K-810.60%-137.26K
Net intangibles purchase and sale 75.35%-16.57K91.29%-171.78K97.88%-38.04K67.01%-41.93K30.34%-24.62K-350.60%-67.19K-685.74%-1.97M-2,451.73%-1.79M-163.23%-127.11K-5.67%-35.34K
Net business purchase and sale ------0--0--0-----------13.5M--0--0--0
Net other investing changes -----81.71%347.36K----------------3,513.07%1.9M295.93%1M--------
Cash from discontinued investing activities
Investing cash flow 66.65%-58.19K99.23%-105.7K140.68%260.64K-113.96%-95.07K43.91%-96.81K98.71%-174.45K-2,624.58%-13.67M-2,291.39%-640.77K728.95%680.81K-255.76%-172.59K
Financing cash flow
Cash flow from continuing financing activities 236.12%2.42M-260.10%-7.42M46.52%-1.49M55.67%-882.6K-171.12%-3.28M-145.41%-1.78M41.98%-2.06M-278.19%-2.78M-619.86%-1.99M36.52%-1.21M
Net issuance payments of debt 2,683.90%3.3M-384.65%-3.42M90.73%-138.98K82.69%-225K-192.42%-2.92M-102.55%-127.71K--1.2M---1.5M-230.00%-1.3M0.00%-1M
Net common stock issuance -32.33%-247.61K29.68%-740.53K0.36%-188.97K-168.56%-201.65K21.80%-162.79K67.75%-187.12K24.07%-1.05M47.49%-189.66K69.72%-75.09K56.16%-208.17K
Net other financing activities 56.93%-630.7K-47.96%-3.27M-6.23%-1.16M25.99%-455.94K---188.68K-191.98%-1.46M-1.94%-2.21M-191.67%-1.09M-66.96%-616.07K--0
Cash from discontinued financing activities
Financing cash flow 236.12%2.42M-260.10%-7.42M46.52%-1.49M55.67%-882.6K-171.12%-3.28M-145.41%-1.78M41.98%-2.06M-278.19%-2.78M-619.86%-1.99M36.52%-1.21M
Net cash flow
Beginning cash position -7.27%18.32M-26.93%19.76M-5.29%18.51M0.18%18.25M-5.10%16.39M-26.93%19.76M9.24%27.04M-24.38%19.54M-29.04%18.22M-30.72%17.27M
Current changes in cash 106.73%226.86K80.28%-1.44M-186.10%-186.34K-80.46%258.88K96.14%1.86M65.50%-3.37M-418.44%-7.28M-81.93%216.43K666.90%1.32M27.05%949.78K
End cash Position 13.20%18.55M-7.27%18.32M-7.27%18.32M-5.29%18.51M0.18%18.25M-5.10%16.39M-26.93%19.76M-26.93%19.76M-24.38%19.54M-29.04%18.22M
Free cash flow -37.81%-2.19M-11.58%5.64M-52.26%953.4K-52.77%1.14M138.12%5.14M-727.80%-1.59M6.54%6.38M6.22%2M1,249.47%2.42M-18.59%2.16M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Cannabis
Cannabis
Intraday+1.03%